The N501Y spike substitution enhances SARS-CoV-2 transmission

Liu, Yang, Liu, Jianying, Plante, Kenneth S., Plante, Jessica A., Xie, Xuping, Zhang, Xianwen, Ku, Zhiqiang, An, Zhiqiang, Scharton, Dionna, Schindewolf, Craig, Menachery, Vineet D., Shi, Pei-Yong, Weaver, Scott C.·2021·Nature
DOI 10.1101/2021.03.08.434499

Cited by (574)

Items 101–200 of 574

  1. The alpha/B.1.1.7 SARS-CoV-2 variant exhibits significantly higher affinity for ACE-2 and requires lower inoculation doses to cause disease in K18-hACE2 mice
    Rafael Bayarri‐Olmos, Laust Bruun Johnsen, Manja Idorn, Line Sinnathamby Reinert, Anne Rosbjerg, Søren Vang, Cecilie Bo Hansen, Charlotte Helgstrand, Jais Rose Bjelke, Theresa Bak-Thomsen et al. · 2021 · eLife
  2. Drug repurposing for identification of potential spike inhibitors for SARS-CoV-2 using molecular docking and molecular dynamics simulations
    Michał Łaźniewski, Doni Dermawan, Syahrul Hidayat, Muchtaridi Muchtaridi, Wayne Dawson, Dariusz Plewczyński · 2022 · Methods
  3. Investigating the evolutionary origins of the first three SARS-CoV-2 variants of concern
    Mahan Ghafari, Qihan Liu, Arushi Dhillon, Aris Katzourakis, Daniel B. Weissman · 2022 · Frontiers in Virology
  4. Electrostatic Features for the Receptor Binding Domain of SARS-COV-2 Wildtype and Its Variants. Compass to the Severity of the Future Variants with the Charge-Rule
    Fernando Luís Barroso da Silva, Carolina Corrêa Giron, Aatto Laaksonen · 2022 · The Journal of Physical Chemistry B
  5. Reverse genetic systems of SARS-CoV-2 for antiviral research
    Chaitanya Kurhade, Xuping Xie, Pei‐Yong Shi · 2022 · Antiviral Research
  6. The Immune Response to SARS-CoV-2 and Variants of Concern
    Elham Torbati, Kurt L. Krause, James E. Ussher · 2021 · Viruses
  7. The Variation of SARS-CoV-2 and Advanced Research on Current Vaccines
    Yao Jiang, Qian Yun Wu, Peipei Song, Chongge You · 2022 · Frontiers in Medicine
  8. SARS-CoV-2 Variants of Concern Infect the Respiratory Tract and Induce Inflammatory Response in Wild-Type Laboratory Mice
    Shannon Stone, Hussin A. Rothan, Janhavi Prasad Natekar, Pratima Kumari, Shaligram Sharma, Heather Pathak, Komal Arora, Tabassum Tasnim Auroni, Mukesh Kumar · 2021 · Viruses
  9. Mutations in SARS-CoV-2 variant nsp6 enhance type-I interferon antagonism
    Cody J. Bills, Hongjie Xia, John Yun-Chung Chen, Jason Yeung, Birte Kalveram, David Hughes Walker, Xuping Xie, Pei‐Yong Shi · 2023 · Emerging Microbes & Infections
  10. The consequences of SARS-CoV-2 within-host persistence
    Alex Sigal, Richard A. Neher, Richard John Lessells · 2024 · Nature Reviews Microbiology
  11. Inferring effects of mutations on SARS-CoV-2 transmission from genomic surveillance data
    Brian Lee, Ahmed Abdul Quadeer, Muhammad Saqib Sohail, Elizabeth Finney, Syed Faraz Ahmed, Matthew R. McKay, John P. Barton · 2025 · Nature Communications
  12. RBD-homodimer, a COVID-19 subunit vaccine candidate, elicits immunogenicity and protection in rodents and nonhuman primates
    Xiaoyan Pan, Jian R. Shi, Xue Hu, Yan Ling Wu, Liang Zeng, Yanfeng Yao, Weijuan Shang, Kunpeng Liu, Ge Gao, Weiwei Guo et al. · 2021 · Cell Discovery
  13. Evolution of SARS-CoV-2 in Spain during the First Two Years of the Pandemic: Circulating Variants, Amino Acid Conservation, and Genetic Variability in Structural, Non-Structural, and Accessory Proteins
    Paloma Troyano-Hernáez, Roberto Reinosa, África Holguín · 2022 · International Journal of Molecular Sciences
  14. The NSP4 T492I mutation increases SARS-CoV-2 infectivity by altering non-structural protein cleavage
    Xiaoyuan Lin, Zhou Sha, Jakob Trimpert, Dušan Kunec, Chen Jiang, Yan Xiong, Binbin Xu, Zhenglin Zhu, Weiwei Xue, Haibo Wu · 2023 · Cell Host & Microbe
  15. Replicative Fitness of a SARS-CoV-2 20I/501Y.V1 Variant from Lineage B.1.1.7 in Human Reconstituted Bronchial Epithelium
    Franck Touret, Léa Lucıanı, Cécile Baronti, Maxime Cochin, Jean‐Sélim Driouich, Magali Gilles, Laurence Thirion, Antoine Nougaırède, Xavier Nicolas de Lamballerie · 2021 · mBio
  16. A structure-function analysis shows SARS-CoV-2 BA.2.86 balances antibody escape and ACE2 affinity
    Chang Liu, Daming Zhou, Aiste Dijokaite-Guraliuc, Piyada Supasa, Helen M. E. Duyvesteyn, Helen Mary Ginn, Muneeswaran Selvaraj, Alexander J. Mentzer, Raksha Das, Thushan I. de Silva et al. · 2024 · Cell Reports Medicine
  17. Human coronavirus OC43-elicited CD4+ T cells protect against SARS-CoV-2 in HLA transgenic mice
    Rúbens Prince dos Santos Alves, Julia Timis, Robyn Miller, Kristen M. Valentine, Paolla Beatriz Almeida Pinto, Andrew Gonzalez, José Ángel Regla-Nava, Erin Maule, Michael N. Nguyen, Norazizah Shafee et al. · 2024 · Nature Communications
  18. The Spike Protein of SARS-CoV-2 Is Adapting Because of Selective Pressures
    Georgina I. López-Cortés, Miryam Palacios-Pérez, Hannya F. Veledíaz, Margarita M. Hernández-Aguilar, Gerardo R. López-Hernández, Gabriel S. Zamudio, Marco V. José · 2022 · Vaccines
  19. Evolution of Omicron lineage towards increased fitness in the upper respiratory tract in the absence of severe lung pathology
    Arthur Wickenhagen, Meaghan Flagg, Julia Rebecca Port, Claude Kwe Yinda, Kerry Goldin, Shane Gallogly, Jonathan E. Schulz, Tessa R. Lutterman, Brandi N. Williamson, Franziska Karola Kaiser et al. · 2025 · Nature Communications
  20. Interaction Analysis of the Spike Protein of Delta and Omicron Variants of SARS-CoV-2 with hACE2 and Eight Monoclonal Antibodies Using the Fragment Molecular Orbital Method
    Sungbo Hwang, Seung‐Hwa Baek, Daeui Park · 2022 · Journal of Chemical Information and Modeling
  21. The Role of Cellular Immunity in the Protective Efficacy of the SARS-CoV-2 Vaccines
    Zhongjie Sun, Tingxin Wu, Huangfan Xie, Yuhuan Li, Jinlan Zhang, Xun‐Cheng Su, Hailong Qi · 2022 · Vaccines
  22. Reduced airborne transmission of SARS-CoV-2 BA.1 Omicron virus in Syrian hamsters
    Adrianus C. M. Boon, Tamarand L. Darling, Peter Halfmann, John Franks, Richard J. Webby, Dan H. Barouch, Julia Rebecca Port, Vincent Jacobus Munster, Michael Diamond, Yoshihiro Kawaoka · 2022 · PLoS Pathogens
  23. Decreased Interfacial Dynamics Caused by the N501Y Mutation in the SARS-CoV-2 S1 Spike:ACE2 Complex
    Wesam S. Ahmed, Angelin M. Philip, Kabir Hassan Biswas · 2022 · Frontiers in Molecular Biosciences
  24. Free energy perturbation calculations of mutation effects on SARS-CoV-2 RBD::ACE2 binding affinity
    Sergeeva, Alina P., Katsamba, Phinikoula S., Liao, Junzhuo, Sampson, Jared M., Bahna, Fabiana, Mannepalli, Seetha, Morano, Nicholas C., Shapiro, Lawrence, Friesner, Richard A., Honig, Barry · 2023 · Journal of Molecular Biology
  25. Hallmarks of Severe COVID-19 Pathogenesis: A Pas de Deux Between Viral and Host Factors
    Roberta Rovito, Matteo Augello, Assaf Ben-Haim, Valeria Bono, Antonella d’Arminio Monforte, Giulia Carla Marchetti · 2022 · Frontiers in Immunology
  26. Structural insights into the binding of SARS-CoV-2, SARS-CoV, and hCoV-NL63 spike receptor-binding domain to horse ACE2
    Jun Lan, Peng Chen, Weiming Liu, Wenlin Ren, Linqi Zhang, Qiang Ding, Qi Zhang, Xinquan Wang, Jiwan Ge · 2022 · Structure
  27. Effect of polymorphism in Rhinolophus affinis ACE2 on entry of SARS-CoV-2 related bat coronaviruses
    Pei Shan Li, Jiaxin Hu, Yan Liu, Xiuyuan Ou, Zhixia Mu, Lu Xing, Fuwen Zan, Mengmeng Cao, Lin Tan, Siwen Dong et al. · 2023 · PLoS Pathogens
  28. Do pathogens always evolve to be less virulent? The virulence–transmission trade-off in light of the COVID-19 pandemic
    Ádám Kun, András G. Hubai, Adrienn Král, Judit Mokos, Benjámin Áron Mikulecz, Ádám Radványi · 2023 · Biologia Futura
  29. Electrical Detection Assay Based on Programmable Nucleic Acid Probe for Efficient Single-Nucleotide Polymorphism Identification
    Yun Zhang, Bo Chen, Duo Chen, Yiming Wang, Qingqing Lu, Jie Tan, Long Chen, Liping Zhou, Weihong Tan, Yanbing Yang et al. · 2023 · ACS Sensors
  30. Reverse genetics systems for SARS-CoV-2: Development and applications
    Hou-Li Cai, Yao‐Wei Huang · 2023 · Virologica Sinica
  31. Infection and transmission of ancestral SARS-CoV-2 and its alpha variant in pregnant white-tailed deer
    Konner R. Cool, Natasha N. Gaudreault, Igor Morozov, Jessie D. Trujillo, David A. Meekins, Chester D. McDowell, Mariano Carossino, Dashzeveg Bold, Taeyong Kwon, Velmurugan Balaraman et al. · 2021 · bioRxiv (Cold Spring Harbor Laboratory)
  32. Effect of SARS-CoV-2 Mutations on the Efficacy of Antibody Therapy and Response to Vaccines
    Ahmed Yaqinuddin, Areez Shafqat, Junaid Kashir, Khaled Manae AlKattan · 2021 · Vaccines
  33. COVID-19 Delta variants—Current status and implications as of August 2021
    Flora Yu, Lok Ting Lau, Manson Fok, Johnson Yiu‐Nam Lau, Kang Zhang · 2021 · Precision Clinical Medicine
  34. Functional Effects of Receptor-Binding Domain Mutations of SARS-CoV-2 B.1.351 and P.1 Variants
    Rafael Bayarri‐Olmos, Ida Jarlhelt, Laust Bruun Johnsen, Cecilie Bo Hansen, Charlotte Helgstrand, Jais Rose Bjelke, Finn Matthiesen, Susanne Dam Nielsen, Kasper Karmark Iversen, Sisse Rye Ostrowski et al. · 2021 · Frontiers in Immunology
  35. Human coronaviruses: The emergence of SARS-CoV-2 and management of COVID-19
    Magan Solomon, Chen Liang · 2022 · Virus Research
  36. Comparative analysis of SARS‐CoV‐2 Omicron BA.2.12.1 and BA.5.2 variants
    Chon Phin Ong, Zi‐Wei Ye, Kaiming Tang, Ronghui Liang, Yubin Xie, Hongzhuo Zhang, Zhenzhi Qin, Haoran Sun, Tong-Yun Wang, Yun Cheng et al. · 2022 · Journal of Medical Virology
  37. Molecular Epidemiology of SARS-CoV-2: The Dominant Role of Arginine in Mutations and Infectivity
    Harry F. Ridgway, Charalampos Ntallis, Christos T. Chasapis, Konstantinos Kelaidonis, Minos–Timotheos Matsoukas, Panagiotis Plotas, Vasso Apostolopoulos, Graham J. Moore, Sotirios Tsiodras, Dimitrios N. Paraskevis et al. · 2023 · Viruses
  38. Zooanthroponotic transmission of SARS-CoV-2 and host-specific viral mutations revealed by genome-wide phylogenetic analysis
    Sana Naderi, Peter E. Chen, Carmen Lía Murall, Raphaël Poujol, Susanne A. Kraemer, Bradley Pickering, Selena M. Sagan, B. Jesse Shapiro · 2023 · eLife
  39. Mechanistic insights into the effects of key mutations on SARS-CoV-2 RBD–ACE2 binding
    Abhishek Aggarwal, Supriyo Naskar, Nikhil Maroli, Biswajit Gorai, Narendra M. Dixit, Prabal Kumar Maiti · 2021 · Physical Chemistry Chemical Physics
  40. De novo selected hACE2 mimics that integrate hotspot peptides with aptameric scaffolds for binding tolerance of SARS-CoV-2 variants
    Minjong Lee, Byunghwa Kang, Juhwa Lee, Jisun Lee, Sang Taek Jung, Chang Yun Son, Seung Soo Oh · 2022 · Science Advances
  41. Identifying and Overcoming the Sampling Challenges in Relative Binding Free Energy Calculations of a Model Protein:Protein Complex
    Ivy Zhang, Dominic A. Rufa, Iván Pulido, Michael M. Henry, Laura E. Rosen, Kevin Hauser, Sukrit Singh, John D. Chodera · 2023 · Journal of Chemical Theory and Computation
  42. Development of highly sensitive one-step reverse transcription-quantitative PCR for SARS-CoV-2 detection in wastewater
    Sunayana Raya, Bikash Malla, Ocean Thakali, Made Sandhyana Angga, Eiji Haramoto · 2023 · The Science of The Total Environment
  43. The R203M and D377Y mutations of the nucleocapsid protein promote SARS-CoV-2 infectivity by impairing RIG-I-mediated antiviral signaling
    Yongkui Li, Moran Li, Heng Xiao, Feng Liao, Miaomiao Shen, Wei-Wei Ge, Junxian Ou, Yuqing Liu, Lu-Miao Chen, Yue Zhao et al. · 2025 · PLoS Pathogens
  44. SARS-CoV-2 variants Alpha, Beta, Delta and Omicron show a slower host cell interferon response compared to an early pandemic variant
    Larissa Laine, Marika Skön, Elina Väisänen, Ilkka Julkunen, Pamela Österlund · 2022 · Frontiers in Immunology
  45. Mouse-Adapted SARS-CoV-2 MA10 Strain Displays Differential Pulmonary Tropism and Accelerated Viral Replication, Neurodissemination, and Pulmonary Host Responses in K18-hACE2 Mice
    Côme Thieulent, Wellesley Dittmar, Udeni B. R. Balasuriya, Nicholas A. Crossland, Xue Wen, Jüergen A. Richt, Mariano Carossino · 2023 · mSphere
  46. Coordinated evolution at amino acid sites of SARS-CoV-2 spike
    Alexey D. Neverov, Gennady G. Fedonin, Anfisa V. Popova, Daria Bykova, Georgii A. Bazykin · 2023 · eLife
  47. Human brain organoids to explore SARS‐CoV‐2‐induced effects on the central nervous system
    Philipp Niklas Ostermann, Heiner Schaal · 2023 · Reviews in Medical Virology
  48. CD4 + and CD8 + T cells are required to prevent SARS-CoV-2 persistence in the nasal compartment
    Meenakshi Kar, Katherine Johnson, Abigail Vanderheiden, Elizabeth J. Elrod, Katharine A. Floyd, Elizabeth Geerling, E. Taylor Stone, Eduardo Salinas, Stephanie Banakis, Wei Wang et al. · 2024 · Science Advances
  49. Eicosanoid signaling as a therapeutic target in middle-aged mice with severe COVID-19
    Lok-Yin Roy Wong, Jian Hua Zheng, Kevin Wilhelmsen, Kun Li, Miguel E. Ortiz, Nicholas Schnicker, Alejandro A. Pezzulo, Peter J. Szachowicz, Klaus Klumpp, Fred Aswad et al. · 2021 · bioRxiv (Cold Spring Harbor Laboratory)
  50. Low dose inocula of SARS-CoV-2 Alpha variant transmits more efficiently than earlier variants in hamsters
    Bobo Wing-Yee Mok, Honglian Liu, Shaofeng Deng, Jiayan Liu, Jinxia Zhang, Siu-Ying Lau, Siwen Liu, Rachel Chun-Yee Tam, Conor J. Cremin, Timothy Ting-Leung Ng et al. · 2021 · Communications Biology
  51. Emerging SARS-CoV-2 Genotypes Show Different Replication Patterns in Human Pulmonary and Intestinal Epithelial Cells
    Gabriel Augusto Pires de Souza, Marion Le Bideau, Céline Boschi, Lorène Ferreira, Nathalie Wurtz, Christian Albert Devaux, Philippe Colson, Bernard La Scola · 2021 · Viruses
  52. SARS-CoV-2 Variants and Vaccination
    Yang Liu, Jianying Liu, Pei‐Yong Shi · 2022 · Zoonoses
  53. Tetra-primer ARMS-PCR combined with dual-color fluorescent lateral flow assay for the discrimination of SARS-CoV-2 and its mutations with a handheld wireless reader
    Yunxiang Wang, Hong Chen, Hongjuan Wei, Zhen Rong, Shengqi Wang · 2022 · Lab on a Chip
  54. Neutralizing antibody activity against SARS-CoV-2 variants in gestational age–matched mother-infant dyads after infection or vaccination
    Yusuke Matsui, Lin Li, Mary K. Prahl, Arianna G. Cassidy, Nida Özarslan, Yarden Golan, Veronica J. Gonzalez, Christine Y. Lin, Unurzul Jigmeddagva, Megan A. Chidboy et al. · 2022 · JCI Insight
  55. Key mutations on spike protein altering ACE2 receptor utilization and potentially expanding host range of emerging SARS‐CoV‐2 variants
    Qiong Wang, Sheng‐Bao Ye, Zhijian Zhou, Jin‐Yan Li, Jizhou Lv, Bodan Hu, Shuofeng Yuan, Ye Qiu, Xing‐Yi Ge · 2022 · Journal of Medical Virology
  56. RT-RPA-Cas12a-based assay facilitates the discrimination of SARS-CoV-2 variants of concern
    Guiyue Tang, Zilong Zhang, Wei Liang Tan, Fei Long, Jingxian Sun, Yingying Li, Siwei Zou, Yujiao Yang, Kezhu Cai, Shenwei Li et al. · 2023 · Sensors and Actuators B Chemical
  57. The SARS-CoV-2 Omicron (B.1.1.529) variant exhibits altered pathogenicity, transmissibility, and fitness in the golden Syrian hamster model
    Shuo-Feng Yuan, Zi-Wei Ye, R. Liang, K. Tang, A. Zhang, G. Lu, C. Ong, V. Poon, C. Chan, Bo-Bo W. Mok et al. · 2022 · bioRxiv
  58. Continent-wide evolutionary trends of emerging SARS-CoV-2 variants: dynamic profiles from Alpha to Omicron
    Chiranjib Chakraborty, Manojit Bhattacharya, Ashish Ranjan Sharma, Kuldeep Dhama, Sang‐Soo Lee · 2022 · GeroScience
  59. Increased flexibility of the SARS-CoV-2 RNA-binding site causes resistance to remdesivir
    Shiho Torii, Kwang Su Kim, Jun Koseki, Rigel Suzuki, Shoya Iwanami, Yasuhisa Fujita, Yong Dam Jeong, Jumpei Ito, Hiroyuki Asakura, Mami Nagashima et al. · 2023 · PLoS Pathogens
  60. Structural definition of HLA class II-presented SARS-CoV-2 epitopes reveals a mechanism to escape pre-existing CD4+ T cell immunity
    Yuan Chen, Georgina H. Mason, David Oliver Scourfield, Alexander Greenshields‐Watson, Tracey A. Haigh, Andrew Kelvin Sewell, Heather M. Long, Awen Gallimore, P.J. Rizkallah, Bruce J. MacLachlan et al. · 2023 · Cell Reports
  61. The mutation rate of SARS-CoV-2 is highly variable between sites and is influenced by sequence context, genomic region, and RNA structure
    Hugh K. Haddox, Georg Angehrn, Luca Sesta, Chris Jennings-Shaffer, Seth D Temple, Jared Galloway, Angie S. Hinrichs, William S. DeWitt, Jesse D. Bloom, Frederick A. Matsen IV et al. · 2025 · Nucleic Acids Research
  62. Dynamics of SARS-CoV-2 mutations reveals regional-specificity and similar trends of N501 and high-frequency mutation N501Y in different levels of control measures
    Santiago Justo Arévalo, Daniela Zapata Sifuentes, César J. Huallpa, Gianfranco Landa Bianchi, Adriana Castillo Chávez, Romina Garavito-Salini Casas, Carmen Sofia Uribe Calampa, Guillermo Uceda-Campos, Roberto Pineda · 2021 · Scientific Reports
  63. The Spike-Stabilizing D614G Mutation Interacts with S1/S2 Cleavage Site Mutations To Promote the Infectious Potential of SARS-CoV-2 Variants
    Stacy Gellenoncourt, Nell Saunders, Rémy Robinot, Lucas Auguste, Maaran Michael Rajah, Jérôme Kervevan, Raphaël Jeger‐Madiot, Isabelle Staropoli, Cyril Planchais, Hugo Mouquet et al. · 2022 · Journal of Virology
  64. Syrian hamster convalescence from prototype SARS-CoV-2 confers measurable protection against the attenuated disease caused by the Omicron variant
    Kathryn A. Ryan, Kevin R. Bewley, Robert J. Watson, Christopher Burton, Oliver T. Carnell, Breeze E. Cavell, Amy Challis, Naomi S. Coombes, Elizabeth R. Davies, Jack Edun-Huges et al. · 2023 · PLoS Pathogens
  65. Prevalence of symptoms, comorbidities, and reinfections in individuals infected with Wild-Type SARS-CoV-2, Delta, or Omicron variants: a comparative study in western Mexico
    Marcela Peña Rodríguez, Jorge Hernández‐Bello, Natali Vega‐Magaña, Oliver Viera Segura, Mariel García‐Chagollán, Hazael Ramiro Ceja-Gálvez, Jesús Carlos Mora Mora, Francisco Israel Renteria-Flores, Octavio Patricio García-González, José Francisco Muñoz Valle · 2023 · Frontiers in Public Health
  66. Nanoemulsions and nanocapsules as carriers for the development of intranasal mRNA vaccines
    Mireya L. Borrajo, Gustavo Lou, Shubaash Anthiya, Philipp Lapuhs, David Moreira, Araceli Tobío, Marı́a Isabel Loza, Anxo Vidal, Marı́a José Alonso · 2024 · Drug Delivery and Translational Research
  67. Follow-up investigation and detailed mutational characterization of the SARS-CoV-2 Omicron variant lineages (BA.1, BA.2, BA.3 and BA.1.1)
    Qussai Abbas, Кусакин Алексей Викторович, Kinda Ali Sharrouf, Susan Jyakhwo, Aleksey S. Komissarov · 2022 · bioRxiv (Cold Spring Harbor Laboratory)
  68. Missense variants in human ACE2 strongly affect binding to SARS-CoV-2 Spike providing a mechanism for ACE2 mediated genetic risk in Covid-19: A case study in affinity predictions of interface variants
    Stuart A. MacGowan, Michael I. Barton, Mikhail A. Kutuzov, Omer Dushek, P. Anton van der Merwe, Geoffrey J. Barton · 2022 · PLoS Computational Biology
  69. Fractal–fractional age-structure study of omicron SARS-CoV-2 variant transmission dynamics
    Emmanuel Addai, Lingling Zhang, Joshua Kiddy K. Asamoah, Ama Kyerewaa Preko, Yarhands Dissou Arthur · 2022 · Partial Differential Equations in Applied Mathematics
  70. Comparative Aerosol and Surface Stability of SARS-CoV-2 Variants of Concern
    Trenton Bushmaker, Claude Kwe Yinda, Dylan H. Morris, Myndi G. Holbrook, Amandine Gamble, Danielle R. Adney, Cara Bushmaker, Neeltje van Doremalen, Robert J. Fischer, Raina K. Plowright et al. · 2023 · Emerging infectious diseases
  71. The SARS-CoV-2 Alpha variant exhibits comparable fitness to the D614G strain in a Syrian hamster model
    Maxime Cochin, Léa Lucıanı, Franck Touret, Jean‐Sélim Driouich, Paul-Rémi Petit, Grégory Moureau, Cécile Baronti, Caroline Laprie, Laurence Thirion, Piet Maes et al. · 2022 · Communications Biology
  72. SARS-CoV-2: The Interplay Between Evolution and Host Immunity
    James Brett Case, Shilpi Jain, Mehul S. Suthar, Michael Diamond · 2024 · Annual Review of Immunology
  73. Biological Significance of the Genomic Variation and Structural Dynamics of SARS-CoV-2 B.1.617
    Lin-qian Fan, Xiao-yun Hu, Yiyue Chen, Xiang-Lei Peng, Yuan-Hui Fu, Yan-Peng Zheng, Jie‐mei Yu, Jinsheng He · 2021 · Frontiers in Microbiology
  74. Convergent Evolution of Multiple Mutations Improves the Viral Fitness of SARS-CoV-2 Variants by Balancing Positive and Negative Selection
    Vaibhav Upadhyay, Casey Patrick, Alexandra Lucas, Krishna M.G. Mallela · 2022 · Biochemistry
  75. Receptor binding domain proteins of SARS‐CoV‐2 variants produced in Nicotiana benthamiana elicit neutralizing antibodies against variants of concern
    Narach Khorattanakulchai, Suwimon Manopwisedjaroen, Kaewta Rattanapisit, Chalisa Panapitakkul, Taratorn Kemthong, Nutchanat Suttisan, Kanjana Srisutthisamphan, Suchinda Malaivijitnond, Arunee Thitithanyanont, Anan Jongkaewwattana et al. · 2022 · Journal of Medical Virology
  76. Whole genome sequencing analysis of SARS-CoV-2 from Malaysia: From alpha to Omicron
    Choo Yee Yu, Sie Yeng Wong, Nancy Woan Charn Liew, Narcisse Mary Sither Joseph, Zunita Zakaria, Nurulfiza Mat Isa, Hui Jen Soe, Rachna Kairon, Syafinaz Amin Nordin, Hui‐Yee Chee · 2022 · Frontiers in Medicine
  77. Cell-targeted gene modification by delivery of CRISPR-Cas9 ribonucleoprotein complexes in pseudotyped lentivirus-derived nanoparticles
    Ian Helstrup Nielsen, Anne Bruun Rovsing, Jacob Hørlück Janns, Emil Aagaard Thomsen, Albert Ruzo, Andreas Bøggild, Frederikke Nedergaard, Charlotte Thornild Møller, Thomas P. Boesen, Søren Egedal Degn et al. · 2024 · Molecular Therapy — Nucleic Acids
  78. Virion morphology and on-virus spike protein structures of diverse SARS-CoV-2 variants
    Zunlong Ke, Thomas P. Peacock, Jonathan C. Brown, Carol Sheppard, Tristan Ian Croll, Abhay Kotecha, Daniel H. Goldhill, William Barclay, John A. G. Briggs · 2024 · The EMBO Journal
  79. Computational analysis of the effect of SARS-CoV-2 variant Omicron Spike protein mutations on dynamics, ACE2 binding and propensity for immune escape
    Natália Teruel, Matthew R. Crown, Matthew Bashton, Rafaël Najmanovich · 2021 · bioRxiv (Cold Spring Harbor Laboratory)
  80. Structural and computational insights into the SARS-CoV-2 Omicron RBD-ACE2 interaction
    Jun Lan, Xinheng He, Yifei Ren, Ziyi Wang, Huan Zhou, Shilong Fan, Chenyou Zhu, Dongsheng Liu, Bin Shao, Tie‐Yan Liu et al. · 2022 · bioRxiv (Cold Spring Harbor Laboratory)
  81. The nervous system during COVID ‐19: Caught in the crossfire
    Nick R. Natale, John R. Lukens, William A. Petri · 2022 · Immunological Reviews
  82. Cross-neutralization and viral fitness of SARS-CoV-2 Omicron sublineages
    Hongjie Xia, Jason Yeung, Birte Kalveram, Cody J. Bills, John Yun-Chung Chen, Chaitanya Kurhade, Jing Zou, Steven G. Widen, Brian R. Mann, Rebecca J Garten Kondor et al. · 2023 · Emerging Microbes & Infections
  83. SARS-CoV-2 Spike-Mediated Entry and Its Regulation by Host Innate Immunity
    Shi Yu, Huina Hu, Qiangyun Ai, Rong Bai, Kaixiong Ma, Minmin Zhou, Shaobo Wang · 2023 · Viruses
  84. Emerging variants develop total escape from potent monoclonal antibodies induced by BA.4/5 infection
    Chang Liu, Raksha Das, Aiste Dijokaite-Guraliuc, Daming Zhou, Alexander J. Mentzer, Piyada Supasa, Muneeswaran Selvaraj, Helen M. E. Duyvesteyn, Thomas G. Ritter, Nigel James Temperton et al. · 2024 · Nature Communications
  85. A Bioluminescent 3CLPro Activity Assay to Monitor SARS-CoV-2 Replication and Identify Inhibitors
    Cyrille Mathieu, Franck Touret, Clémence Jacquemin, Yves Louis Janin, Antoine Nougaırède, Manon Brailly, Magalie Mazelier, Didier Décimo, Virginie Vasseur, Aymeric Hans et al. · 2021 · Viruses
  86. S:D614G and S:H655Y are Gateway Mutations that Act Epistatically to Promote SARS-CoV-2 Variant Fitness
    Leonid Yurkovetskiy, Shawn B. Egri, Chaitanya Kurhade, Marco Aurelio Díaz-Salinas, Javier A. Jaimes, Thomas Nyalile, Xuping Xie, Manish Chandra Choudhary, Ann Dauphin, Jonathan Z. Li et al. · 2023 · SSRN Electronic Journal
  87. Predicting pathogen evolution and immune evasion in the age of artificial intelligence
    David J. Hamelin, Matthew Scicluna, I Saadie, Fatima Mostefai, Jean‐Christophe Grenier, Cantin Baron, Étienne Caron, Julie Hussin · 2025 · Computational and Structural Biotechnology Journal
  88. SARS-CoV-2 Virion Infectivity and Cytokine Production in Primary Human Airway Epithelial Cells
    Thuc Nguyen Dan, Sandra Claes, Dominique Schols, Johan H. Neyts, Dirk Jochmans · 2022 · Viruses
  89. Host genetic diversity and genetic variations of SARS-CoV-2 in COVID-19 pathogenesis and the effectiveness of vaccination
    Mahda Delshad, Mohammad‐Javad Sanaei, Atieh Pourbagheri‐Sigaroodi, Davood Bashash · 2022 · International Immunopharmacology
  90. SARS-CoV-2 Variants, Current Vaccines and Therapeutic Implications for COVID-19
    Hongyu Liang, Yuyan Wu, Vicky Yau, Huan-Xin Yin, Scott Lowe, Rachel Bentley, Mubashir Ayaz Ahmed, Wenjing Zhao, Chenyu Sun · 2022 · Vaccines
  91. The impact of S2 mutations on Omicron SARS-CoV-2 cell surface expression and fusogenicity
    Alba Escalera, Manon Laporte, Sam Turner, Umut Karakus, Ana Silvia Gonzalez-Reiche, Adriana van de Guchte, Keith Farrugia, Zain Khalil, Harm van Bakel, Derek J. Smith et al. · 2023 · Emerging Microbes & Infections
  92. Mutational Hotspot in the SARS-CoV-2 Spike Protein N-Terminal Domain Conferring Immune Escape Potential
    Slawomir Kubik, Nils Arrigo, Jaume Bonet, Zhenyu Xu · 2021 · Viruses
  93. Establishment of a pseudovirus neutralization assay based on SARS-CoV-2 S protein incorporated into lentiviral particles
    Sheng Wang, Lizhen Liu, Can Wang, Ziqiang Wang, Xuhua Duan, Gang Chen, Hu Zhou, Hong Shao · 2022 · Biosafety and Health
  94. mRNA-1273 and Ad26.COV2.S vaccines protect against the B.1.621 variant of SARS-CoV-2
    Tamarand L. Darling, Baoling Ying, Bradley M. Whitener, Laura A. VanBlargan, Traci L. Bricker, Chieh-Yu Liang, Astha Joshi, Gayan Bamunuarachchi, Kuljeet Seehra, Aaron J. Schmitz et al. · 2022 · Med
  95. Molecular epidemiological features of SARS-CoV-2 in Japan, 2020–1
    Hirotaka Ode, Yoshihiro Nakata, Mami Nagashima, Masaki Hayashi, Takako Yamazaki, Hiroyuki Asakura, Jun Suzuki, Mai Kubota, Kazuhiro Matsuoka, Masakazu Matsuda et al. · 2022 · Virus Evolution
  96. Molecular characterization of SARS-CoV-2 detected in Tokyo, Japan during five waves: Identification of the amino acid substitutions associated with transmissibility and severity
    Koji Tsuchiya, Norio Yamamoto, Yoshie Hosaka, Mitsuru Wakita, Makoto Hiki, Yasushi Matsushita, Hirotake Mori, Satoshi Hori, Shigeki Misawa, Takashi Miida et al. · 2022 · Frontiers in Microbiology
  97. Peimine inhibits variants of SARS‐CoV ‐2 cell entry via blocking the interaction between viral spike protein and ACE2
    Wei‐Jan Wang, Yeh Chen, Wen‐Chi Su, Yen‐Yi Liu, Wan‐Jou Shen, Wei‐Chao Chang, Sheng‐Teng Huang, Cheng‐Wen Lin, Yu‐Chuan Wang, Chia‐Shin Yang et al. · 2022 · Journal of Food Biochemistry
  98. Convalescence from prototype SARS-CoV-2 protects Syrian hamsters from disease caused by the Omicron variant
    Kathryn A. Ryan, Robert J. Watson, Kevin R. Bewley, Christopher Burton, Oliver T. Carnell, Breeze E. Cavell, Amy Challis, Naomi S. Coombes, Kirsty Emery, Rachel Fell et al. · 2021 · bioRxiv (Cold Spring Harbor Laboratory)
  99. SARS-CoV-2 spike mutations alter structure and energetics to modulate ACE2 binding immune evasion and viral adaptation
    Farid Shokry Ataya, Abir Abdullah Alamro, Amani Ahmed Alghamdi, Dalia Fouad · 2025 · Scientific Reports
  100. Full-Length Recombinant hSP-D Binds and Inhibits SARS-CoV-2
    Raquel Arroyo, Shawn N. Grant, Miriam Colombo, Lucia Salvioni, Fabio Corsi, Marta Truffi, Davide Ottolina, Brett L. Hurst, Marc Oliver Salzberg, Davide Prosperi et al. · 2021 · Biomolecules